C12N 2750/10023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2750/10023 (Virus like particles [vlp]) appears on 20 US grants and 35 published applications in this corpus.
Search patents in C12N- Granted patents
- 20
- Published applications
- 35
- Assignees
- 15
- Inventors
- 57
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 7 |
| 2009 | 0 | 0 |
| 2010 | 3 | 0 |
| 2011 | 1 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 2 | 4 |
| 2016 | 1 | 3 |
| 2017 | 3 | 2 |
| 2018 | 2 | 2 |
| 2019 | 0 | 1 |
| 2020 | 2 | 3 |
| 2021 | 1 | 3 |
| 2022 | 1 | 4 |
| 2023 | 0 | 0 |
| 2024 | 2 | 1 |
| 2025 | 1 | 2 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Porcine circovirus type 2 VLP vaccine6 Jan 2026US 12,514,916 B2Meiji Animal Health Co., Ltd.
- PCV2 ORF2 protein variant and virus like particles composed thereof11 Mar 2025US 12,247,051 B2
- Recombinant vector for expressing virus-like particles in plant and method for preparation of vaccine composition containing circovirus-like particles by using same3 Dec 2024US 12,156,907 B2Bioapplications Inc.
- PCV2 ORF2 protein variant and virus like particles composed thereof2 Jan 2024US 11,858,963 B2
- Recombinant expression of PCV2b ORF2 protein in insect cells22 Mar 2022US 11,279,952 B2Intervet Inc.
- In vitro assembly of anellovirus capsids enclosing rna14 Aug 2025US 2025/0257368 A1Flagship Pioneering Innovations V, Inc.
- Pcv2 orf2 protein variant and virus like particles composed thereof31 Jul 2025US 2025/0243246 A1Boehringer Ingelheim Animal Health USA Inc.
- Pcv2 orf2 protein variant and virus like particles composed thereof7 Mar 2024US 2024/0076321 A1Boehringer Ingelheim Animal Health USA Inc.
- In vitro assembly of anellovirus capsids enclosing rna24 Nov 2022US 2022/0372519 A1Flagship Pioneering Innovations V, Inc.
- Porcine circovirus type 2 vlp vaccine22 Sep 2022US 2022/0296697 A1KM Biologics Co., Ltd.
Most cited
By later US patents
- Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs42US 7,829,273 B2Boehringer Ingelheim Vetmedica GmbH · 2010
- Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs31US 7,838,213 B2Boehringer Ingelheim Vetmedica GmbH · 2010
- Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs31US 7,838,214 B2Boehringer Ingelheim Vetmedical, Inc. · 2010
- Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs31US 7,968,285 B2Boehringer Ingelheim Vetmedica GmbH · 2011
- Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs22US 9,011,868 B2Boehringer Ingelheim Vetmedica GmbH · 2015